Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Scheiflinger

Showing results (81-90 of 85) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 85 results.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2019
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and MonkeysHelmut Glantschnig, Alexander Bauer, Karima Benamara, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
Blood|December 14, 2006
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activitySilvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2020
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy EfficiencyWenjing Cao, Biao Dong, Franziska Horling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
Pageof 9

Showing results (81-90 of 85) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 85 results.
The Journal of Pharmacology and Experimental Therapeutics|August 2, 2019
Evaluation of Factor VIII Polysialylation: Identification of a Longer-Acting Experimental Therapy in Mice and MonkeysHelmut Glantschnig, Alexander Bauer, Karima Benamara, et al.
Blood|October 17, 2020
BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expressionBarbara A Konkle, Christopher E Walsh, Miguel A Escobar, et al.
Blood|December 14, 2006
Prognostic value of anti-ADAMTS 13 antibody features (Ig isotype, titer, and inhibitory effect) in a cohort of 35 adult French patients undergoing a first episode of thrombotic microangiopathy with undetectable ADAMTS 13 activitySilvia Ferrari, Friedrich Scheiflinger, Manfred Rieger, et al.
Molecular Therapy. Methods & Clinical Development|December 14, 2020
Minimal Essential Human Factor VIII Alterations Enhance Secretion and Gene Therapy EfficiencyWenjing Cao, Biao Dong, Franziska Horling, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 26, 2015
Selective Targeting of a Disease-Related Conformational Isoform of Macrophage Migration Inhibitory Factor Ameliorates Inflammatory ConditionsMichael Thiele, Randolf J Kerschbaumer, Frederick W K Tam, et al.
Pageof 9